Racial disparities in treatment of high-grade endometrial cancer in the medicare population

Obstetrics and Gynecology

Volumn 125, Issue 4, 2015, Pages 843-851

  Alejandro Rauh Hain, J ^a   Buskwofie, Ama ^a   Clemmer, Joel ^a   Boruta, David M ^a   Schorge, John O ^a   Del Carmen, Marcela G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; AGED; CANCER MORTALITY; CANCER SURVIVAL; CARCINOSARCOMA; CAUCASIAN; CLEAR CELL CARCINOMA; COMORBIDITY; CONFERENCE PAPER; DISEASE SPECIFIC SURVIVAL; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; MEDICARE; OVERALL SURVIVAL; PATIENT CARE; PRIORITY JOURNAL; RACISM; RURAL AREA; SOCIAL STATUS; UTERINE CARCINOSARCOMA; UTERUS CARCINOMA; VERY ELDERLY; CANCER REGISTRY; CARCINOMA; ENDOMETRIAL NEOPLASMS; EPIDEMIOLOGY; ETHNOLOGY; HEALTH CARE DISPARITY; MORTALITY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; UNITED STATES;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOSARCOMA; ENDOMETRIAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MEDICARE; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 84925402912     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000605     Document Type: Conference Paper

References (29)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
2. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000;355:1404-11.
3. Wright JD, Barrena Medel NI, Sehouli J, Fujiwara K, Herzog TJ. Contemporary management of endometrial cancer. Lancet 2012;379:1352-60.
4. Acharya S, Hensley ML, Montag AC, Fleming GF. Rare uterine cancers. Lancet Oncol 2005;6:961-71.
5. Long B, Liu FW, Bristow RE. Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States. Gynecol Oncol 2013;130:652-9.
6. Allard JE, Maxwell GL. Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer. Cancer Control 2009;16:53-6.
7. Ghafoor A, Jemal A, Cokkinides V, Cardinez C, Murray T, Samuels A, et al. Cancer statistics for African Americans. CA Cancer J Clin 2002;52:326-41.
8. Farley J, Risinger JI, Rose GS, Maxwell GL. Racial disparities in blacks with gynecologic cancers. Cancer 2007;110: 234-43.
9. Surveillance, Epidemiology, and End Results (SEER) program research data (1988-2009), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2012, based on the November 2011 submission. Available at: www.seer.cancer.gov. Retrieved September 14, 2014.
10. Du XL, Key CR, Dickie L, Darling R, Geraci JM, Zhang D. External validation of Medicare claims for breast cancer chemotherapy compared with medical chart reviews. Med Care 2006;44:124-31.
11. Curtis E, Quale C, Haggstrom D, Smith-Bindman R. Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 2008;112: 171-80.
12. Rauh-Hain JA, Clemmer J, Clark RM, Bradford LS, Growdon WB, Goodman A, et al. Racial disparities and changes in clinical characteristics and survival for vulvar cancer over time. Am J Obstet Gynecol 2013;209:468.e1-10.
13. Rungruang B, Olawaiye AB. Comprehensive surgical staging for endometrial cancer. Rev Obstet Gynecol 2012;5:28-34.
14. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000;53:1258-67.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: 373-83.
16. Rauh-Hain JA, Clemmer J, Bradford LS, Clark RM, Growdon WB, Goodman A, et al. Racial disparities in cervical cancer survival over time. Cancer 2013;119:3644-52.
17. Howard J, Hankey BF, Greenberg RS, Austin DF, Correa P, Chen VW, et al. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer 1992;69:2349-60.
18. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA 2002;287:2106-13.
19. Wright JD, Fiorelli J, Schiff PB, Burke WM, Kansler AL, Cohen CJ, et al. Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time. Cancer 2009;115:1276-85.
20. Randall TC, Armstrong K. Differences in treatment and outcome between African-American and white women with endo-metrial cancer. J Clin Oncol 2003;21:4200-6.
21. Olson SH, Atoria CL, Cote ML, Cook LS, Rastogi R, Soslow RA, et al. The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol Biomarkers Prev 2012;21:753-60.
22. Madison T, Schottenfeld D, James SA, Schwartz AG, Gruber SB. Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival. Am J Public Health 2004;94:2104-11.
23. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 2002;94:334-57.
24. Pérez-Stable EJ, Sabogal F, Otero-Sabogal R, Hiatt RA, McPhee SJ. Misconceptions about cancer among Latinos and Anglos. JAMA 1992;268:3219-23.
25. Womeodu RJ, Bailey JE. Barriers to cancer screening. Med Clin North Am 1996;80:115-33.
26. Eloubeidi MA, Desmond RA, Wilcox CM, Manchikalapati P, Fouad MM, Eltoum I, et al. Prognostic factors for survival in pancreatic cancer: a population-based study. Am J Surg 2006; 192:322-9.
27. Rauh-Hain JA, Del Carmen MG. Treatment for advanced and recurrent endometrial carcinoma: combined modalities. Oncologist 2010;15:852-61.
28. Murphy MM, Simons JP, Ng SC, McDade TP, Smith JK, Shah SA, et al. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarci-noma. Ann Surg Oncol 2009;16:2968-77.
29. Riley GF, Potoskly AL, Klabunde CN, Warren JL, Ballard-Barbash R. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA 1999;281:720-6.